[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Cogent Biosciences, Inc. Common Stock (COGT)

Cogent Biosciences (COGT) stock surges to a 52-week high following positive clinical trial data and FDA designations, despite market volatility and significant short interest.

### About Cogent Biosciences, Inc. Common Stock
Cogent Biosciences, Inc. is a biotechnology company focused on developing therapies for cancer and inflammatory diseases.  
Cogent Biosciences, Inc. Common Stock uses the ticker $COGT for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Cogent Biosciences, Inc. Common Stock (COGT) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Cogent Biosciences, Inc. Common Stock (COGT) market dominance near a 52-week low at XXXXXXX.
- Cogent Biosciences, Inc. Common Stock (COGT) trading volume is up XXXXXX% from the previous X months.
- Cogent Biosciences, Inc. Common Stock (COGT) social dominance is up XXXXXX% from the previous month.
- Cogent Biosciences, Inc. Common Stock (COGT) engagements is up XXXXXX% from the previous month.
- Cogent Biosciences, Inc. Common Stock (COGT) posts created is up XXXXXX% from the previous month.
- Cogent Biosciences, Inc. Common Stock Price hit a 52-Week high of $XXXXX for the hour
- Cogent Biosciences, Inc. Common Stock Price hit an all time of $XXXXX for the hour

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/close.tsv)  
The stock price has surged to a 52-week high, driven by positive clinical trial data and FDA designations, as indicated by recent social media posts highlighting its potential and analyst upgrades. However, ongoing market volatility and significant short interest are creating some headwinds.  

24-Hour: -XXXX%
7-Day: -XXXX%
30-Day: XXXXX%

1-Year High: $XXXXX on 2025-11-26  
1-Year Low: $X on 2025-04-10  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/alt_rank.tsv)  
Cogent Biosciences, Inc. Common Stock (COGT) is currently AltRank #147 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX -XXX  
1-Year High: XXX on 2025-12-05  
1-Year Low: XXX on 2025-12-10  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX +3  
1-Year High: XX on 2025-12-08  
1-Year Low: XX on 2025-11-20  
  
  
### Engagements: XXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/interactions.tsv)  
Current Value: XXXXXX  
Daily Average: XXXXX  
X Week: XXXXXXX +16%  
X Month: XXXXXXX +610%  
X Months: XXXXXXXXX +195%  
X Year: XXXXXXXXX +235%  
1-Year High: XXXXXXX on 2025-07-07  
1-Year Low: XXX on 2024-12-31  

Engagements by network (24h):
X: XXXXXX
YouTube: XX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXXXX +541%  
X Months: XXXXX +2,106%  
X Year: XXXXX +1,170%  
1-Year High: XXXXX on 2025-07-08  
1-Year Low: X on 2025-01-27  

Mentions by network (24h):
X: XXX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Cogent Biosciences, Inc. Common Stock (COGT) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +567%  
X Months: XXXXX +3,535%  
X Year: XXXXX +1,953%  
1-Year High: XXXXX on 2025-07-08  
1-Year Low: X on 2025-01-27  

The most influential creators that mention Cogent Biosciences, Inc. Common Stock in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@monaco_biotech](/creator/twitter/monaco_biotech) | X    | XXXXX     | X     | XXXXX       |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)         | X    | XXXXXX    | X     | XXXXX       |
| [@OzmosiHealth](/creator/twitter/OzmosiHealth)     | X    | XXXXX     | X     | XXX         |
| [@seedy19tron](/creator/twitter/seedy19tron)       | X    | XXXXX     | X     | XXX         |
| [@Bionavgator](/creator/twitter/Bionavgator)       | X    | XXX       | X     | XXX         |
| [@Biotech2k1](/creator/twitter/Biotech2k1)         | X    | XXXXXX    | X     | XXX         |
| [@Biobeats99](/creator/twitter/Biobeats99)         | X    | XXX       | X     | XXX         |
| [@doepke_michel](/creator/twitter/doepke_michel)   | X    | XXXXX     | X     | XXX         |
| [@semodough](/creator/twitter/semodough)           | X    | XXXXXX    | X     | XX          |
| [@marketwirenews](/creator/twitter/marketwirenews) | XX   | XXXXXX    | X     | XX          |

[View More](/list/creators/$cogt/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% no change  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-12  
1-Year Low: XX% on 2025-04-20  

Most Supportive Themes:
- FDA Breakthrough Therapy Designation: (30%) Cogent Biosciences received FDA Breakthrough Therapy Designation for bezuclastinib in Non-Advanced Systemic Mastocytosis.
- Positive Clinical Trial Data: (25%) Upcoming trial readouts (PEAK and APEX) for bezuclastinib are anticipated in Q4 2025, with topline Phase X data expected in November 2025.
- Analyst Ratings and Price Targets: (20%) Raymond James reiterated a Strong Buy rating with a $XX price target, and Guggenheim raised their price target to $XX from $17, reiterating a Buy rating.
  
Most Critical Themes:
- Market Volatility and Mixed Signals: (40%) Despite positive developments, the overall market is experiencing volatility, creating mixed signals for COGT.
- Short Interest: (35%) The stock has a notable short ratio of XXXX and a short float of 15.11%, indicating significant short pressure.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.011%  
X Month: XXXX% +0.036%  
X Months: XXXX% +0.035%  
X Year: XXXX% +0.029%  
1-Year High: XXXXX% on 2025-07-08  
1-Year Low: XXXXXX% on 2025-09-22  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-11-26  
1-Year Low: XXXXXXX% on 2025-12-09  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$cogt/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$cogt/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX -$1.90%  
X Month: $XXXXXXXXXXXXX +$161%  
1-Year High: $XXXXXXXXXXXXX on 2025-11-26  
1-Year Low: $XXXXXXXXXXXXX on 2025-11-04  

### Top Cogent Biosciences, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$COGT Cogent Biosciences presented P2 Mastocytosis Systemic results on 2025-12-08 for Bezuclastinib More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1998503182096372223) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-09T21:21Z 3011 followers, XXX engagements


"After Hours Movers Dec X Top Gainers $BRZE Braze +6.92% $GEV GE Vernova +4.20% $TITN ServiceTitan +2.73% $VVV Valvoline +2.37% $COGT Cogent Biosciences +1.97% Top Losers $AVAV AeroVironment XXXX% $GME GameStop XXXX% $DNLI Denali Therapeutics XXXX% $COLD Americold Realty Trust XXXX% $ATEC Alphatec Holdings 1.98%"  
[X Link](https://x.com/allday_stocks/status/1998502621305360714) [@allday_stocks](/creator/x/allday_stocks) 2025-12-09T21:18Z 2305 followers, XXX engagements


"$COGT I have added to my existing long-term position. I am deeply convinced that this stock is a candidate for a buyout that at least 2-3 big pharma will be fighting over. Thanks for the dips. I will continue to accumulate ✌🏻🤑"  
[X Link](https://x.com/monaco_biotech/status/1998457859290341480) [@monaco_biotech](/creator/x/monaco_biotech) 2025-12-09T18:20Z 6156 followers, 9367 engagements


"@AndyBradley93 Bro thinks $rvmd $tern $celc $cogt are all bought already"  
[X Link](https://x.com/jw929204/status/1998440150335107079) [@jw929204](/creator/x/jw929204) 2025-12-09T17:10Z XXX followers, 1293 engagements